Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer
Status:
Recruiting
Trial end date:
2024-09-10
Target enrollment:
Participant gender:
Summary
This research study is being done to help determine the safety and efficacy of gadolinium
based nanoparticle, Activation and Guidance of Irradiation X (AGuIX), used in conjunction
with MR-guided stereotactic body radiation therapy (SBRT) in the treatment of pancreatic
cancer and lung tumors.